Puma Biotechnology (PBYI) Goodwill & Intangibles (2017 - 2026)

Puma Biotechnology's Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $39.0 million for Q1 2026.

• Quarterly Goodwill & Intangibles fell 20.0% year-over-year to $39.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.0 million (down 20.0% YoY) and the FY2025 annual result came in at $41.4 million, down 19.05% from the prior year.
• Goodwill & Intangibles was $39.0 million for Q1 2026 at Puma Biotechnology, down from $41.4 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $70.6 million in Q4 2022 and bottomed at $39.0 million in Q1 2026.
• A 5-year average of $56.1 million and a median of $58.4 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles advanced 6.78% — and 2026, when it slipped 20.0%.
• Puma Biotechnology's Goodwill & Intangibles stood at $70.6 million in 2022, then slipped by 13.79% to $60.9 million in 2023, then decreased by 16.0% to $51.1 million in 2024, then fell by 19.05% to $41.4 million in 2025, then dropped by 5.88% to $39.0 million in 2026.
• Business Quant data shows PBYI's Goodwill & Intangibles at $39.0 million in Q1 2026, $41.4 million in Q4 2025, and $43.8 million in Q3 2025.